Page last updated: 2024-08-21

oxymetholone and Dyskeratosis Congenita

oxymetholone has been researched along with Dyskeratosis Congenita in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	2 (40.00)	2.80

Authors

Authors	Studies
Dokal, I; Tummala, H; Walne, A	1
Abels, A; Beier, F; Brümmendorf, TH; Isfort, S; Kirschner, M; Panse, J; Rolles, B; Tometten, M; Vieri, M	1
Dan, K; Yamaguchi, H	1
Dokal, I	1
Alter, BP; Giri, N; Green, D; Pitel, PA	1

Reviews

3 review(s) available for oxymetholone and Dyskeratosis Congenita

Article	Year
The biology and management of dyskeratosis congenita and related disorders of telomeres. Expert review of hematology, 2022, Volume: 15, Issue:8 Topics: Biology; Danazol; Dyskeratosis Congenita; Humans; Mutation; Oxymetholone; Telomerase; Telomere	2022
[Bone marrow failure due to telomere associated gene mutation]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2010, Volume: 51, Issue:8 Topics: Animals; Cell Cycle Proteins; Dyskeratosis Congenita; Genes, Dominant; Genes, Recessive; Genes, X-Linked; Hematopoietic Stem Cell Transplantation; Humans; Mice; Mutation; Nuclear Proteins; Oxymetholone; RNA; Telomerase; Telomere; Telomere-Binding Proteins; Transplantation Conditioning; Vidarabine	2010
Inherited aplastic anaemia. The hematology journal : the official journal of the European Haematology Association, 2003, Volume: 4, Issue:1 Topics: Adolescent; Adult; Anemia, Aplastic; Bone Marrow; Cell Cycle Proteins; Child; Child, Preschool; Chromosomes, Human; Chromosomes, Human, X; Dosage Compensation, Genetic; Dyskeratosis Congenita; Fanconi Anemia; Genetic Heterogeneity; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Humans; Nuclear Proteins; Oxymetholone; Prednisolone; Transplantation Conditioning	2003

Other Studies

2 other study(ies) available for oxymetholone and Dyskeratosis Congenita

Article	Year
Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita. International journal of molecular sciences, 2020, Sep-29, Volume: 21, Issue:19 Topics: Androgens; Cell Cycle Proteins; Danazol; Dyskeratosis Congenita; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Mutation; Nandrolone; Nuclear Proteins; Oxymetholone; Primary Cell Culture; RNA; Telomerase; Telomere	2020
Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor. British journal of haematology, 2007, Volume: 138, Issue:6 Topics: Adult; Androgens; Child; Cysts; Drug Therapy, Combination; Dyskeratosis Congenita; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Oxymetholone; Splenic Diseases; Splenic Rupture	2007

Article

Year

Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis Congenita.

International journal of molecular sciences, 2020, Sep-29, Volume: 21, Issue:19

Topics: Androgens; Cell Cycle Proteins; Danazol; Dyskeratosis Congenita; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Mutation; Nandrolone; Nuclear Proteins; Oxymetholone; Primary Cell Culture; RNA; Telomerase; Telomere

2020

Splenic peliosis and rupture in patients with dyskeratosis congenita on androgens and granulocyte colony-stimulating factor.

British journal of haematology, 2007, Volume: 138, Issue:6

Topics: Adult; Androgens; Child; Cysts; Drug Therapy, Combination; Dyskeratosis Congenita; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Oxymetholone; Splenic Diseases; Splenic Rupture

2007